Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,401–2,500 of 2,883
ASK1 promotes inflammation in senescence and aging
(2023) · doi:10.1101/2023.09.20.558729 · Cited by 1
Polyunsaturated lipids kill senescent cells by ferroptosis
D’Ambrosio, M., & Gil, J. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.021 · Cited by 1
EXD2 and WRN exonucleases are required for interstrand crosslink repair in DrosophilaPreprint
Chennuri, P. R., Cox, L. S., & Saunders, R. D. C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/284307 · Cited by 2
Aged dogs and immunosenescence
Tizard, I. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23681-5.00025-1 · Cited by 1
González‐Gualda, E., Ou, H., Macías, D., & Muñoz‐Espín, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00016-x · Cited by 3
Mammalian aging driven by transcription going awry
McCauley, B. S., & Dang, W. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.06.006 · Cited by 1
Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells
Wang, B., Nehme, J., & Demaria, M. (2026) · EMBO Reports · doi:10.1038/s44319-026-00801-9 · Cited by 1
“In vitro functionality of the HSV-tk cassette in p16-3MR cells was demonstrated in the original report and independently reproduced (Baker et al, 2016).”
Future Directions of Research in the Oral Mucosa
Bergmeier, L. A., & Parkinson, E. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-56065-6_13 · Cited by 1
Bazan, N. G., Bhattacharjee, S., Kala-Bhattacharjee, S., Ledet, A. J., & Mukherjee, P. K. (2023) · Research Square · doi:10.21203/rs.3.rs-3185942/v1 · Cited by 1
Cellular Senescence in Aging Mucosal Tissues Is Accentuated by Periodontitis
Ebersole, J. L., & González, O. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_8 · Cited by 1
Compression of morbidity by interventions that steepen the survival curve
(2023) · doi:10.1101/2023.10.04.560871 · Cited by 1
“Senolytic treatments showed life extension using a genetic approach to ablate cells that express p16 22,58 .”
BackgroundPark, S. S., Heo, J., Kang, H. Y., & Park, T. J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103185 · Cited by 1
Lérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
Hara, D., Sasaki, K., Doi, S., Ike, T., Maeda, K., Yoshida, M., Takahashi, A., Osaki, Y., Ishiuchi, N., Maeoka, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402382r · Cited by 3
“However, aberrant and chronic accumulation of senescent cells drives various pathologies, including age-related diseases and tissue deterioration [15], ultimately reducing health and lifespan [14].”
CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis
Sun, J., Geng, A., Song, Z., Chen, L., Zhang, Z.-N., Jiang, Y., & Mao, Z. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2526252123 · Cited by 1
Stimulation of epidermal hyperplasia and tumorigenesis by resident p16INK4a-expressing cells
Azazmeh, N., & Ben‐Porath, I. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1819752 · Cited by 1
Genomic, epigenomic and transcriptomic regulation of cellular senescence
Salekeen, R., Kieu, T. L., Robbins, P. D., Niedernhofer, L. J., & Laux, L. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00982-y · Cited by 4
HIV and Aging in the Era of ART and COVID-19: Symposium Overview
Montano, M. A., LANDAY, A. L., Perkins, M. M., Holstad, M. M., Pallikkuth, S., Pahwa, S. G., & Symposium, H. A. A. I. T. E. O. A. A. C.-1. I.-C. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002837 · Cited by 1
NIH SenNet Consortium: Mapping Senescent Cells in the Human Body to Understand Health and DiseasePreprint
Lee, P., Blood, P. D., Börner, K., Campisi, J., Chen, F., Daldrup-Link, H. E., Jager, P. L. D., Ding, L., Duncan, F. E., Eickelberg, O., et al. (2022) · Preprints.org · doi:10.20944/preprints202207.0160.v1 · Cited by 2
Cell senescence is a cause of frailty
Wan, T., Miwa, S., & von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00013-4 · Cited by 2
Sato, Y., Kawagoe, Y., & Kawamura, K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0348870 · Cited by 1
“These findings established p16 as a biomarker and possible effector of mammalian aging, indicating that elevated p16 levels accumulate as a consequence of aging-related cellular stress rather than serving a homeostatic maintenance function in young tissues [3,4].”
Suppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?
Roato, I., Visca, M., & Mussano, F. D. (2024) · Biomedicines · doi:10.3390/biomedicines12122811 · Cited by 1
Senolytic potential of shea-derived amyrins in senescent fibroblasts
Hirose, M., Watanabe, S., Fujita, Y., Ohta, S., & Sugimoto, M. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf153 · Cited by 1
Correlations between vessel stiffness and biomarkers of senescent cell in elderly patients
Sorokina, A. G., Efimenko, A. Y., Grigorieva, O., Novoseletskaya, E. S., Basalova, N. A., Aleksandrushkina, N. A., Vigovskiy, M. A., Kirillova, K. I., Strazhesko, I. D., Orlov, A. V., et al. (2022) · Kardiologiia · doi:10.18087/cardio.2022.6.n2033 · Cited by 1
Santhanam, A., Momin, Z., Qin, X., Wang, Q., Krishnavajhala, A., Jiang, Q., Walker, K., Kalra, D., Gingras, M., Chao, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.01.729304 · Cited by 2
“Because unregulated senescence can transition from tumor suppressive to pro‑tumorigenic and pro‑aging 31 , these changes suggest that Space radiation and microgravity may accelerate organismal senescence.”
Liu, N., & Liu, T. (2026) · International Urology and Nephrology · doi:10.1007/s11255-026-05271-5 · Cited by 1
Alexandru, A. C., Hormazabal, G. V., Matsui, H., Kasler, H. G., Lore, S., Aguirre, C. G., Roberts, A., Heckenbach, I., Tiwari, R., Kwok, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658841 · Cited by 2
Lin, Y., Yan, M., Shen, L., Wang, Y., He, H., Han, Z., Chen, H., & Liu, A. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf149 · Cited by 1
The Role of lncRNAs and miRNAs in Therapy-Induced Senescence in Neuroblastoma
Jahangiri, L., & Ishola, T. (2022) · Current Molecular Biology Reports · doi:10.1007/s40610-022-00149-8 · Cited by 1
Hu, J., Leisegang, M. S., Looso, M., Dumbović, G., Wittig, J., Drekolia, M.-K., Günther, S., John, D., Siragusa, M., Zukunft, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.05.506654 · Cited by 1
Mocchegiani, E., & Malavolta, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_66-1 · Cited by 3
Fucoidans are senotherapeutics that enhance SIRT6-dependent DNA repairPreprint
Zhang, L. J., Elsallabi, O., Soto-Palma, C., Bartz, J., Salekeen, R., Nunes, A., Xu, W., Lee, K., Hughes, B., Zhang, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.27.650852 · Cited by 1
Negri, S., Milan, M., Rudraboina, R., Tavakol, S., Reyff, Z., Ihuoma, J., Troyano‐Rodriguez, E., Patai, R., Gulej, R., Jung, W., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261444196 · Cited by 2
Lung aging and senescence in health and disease
Hernández‐González, F., Saito, N., Agustí, A. G. N., Sellarés, J., & Faner, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00002-x · Cited by 2
Moving from reactive to preventive medicine
Badimón, L., Padró, T., & Vilahur, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00003-3 · Cited by 1
Malavolta, M. (2016) · Food and Nutrition Report · doi:10.24218/fnr.2015.15
Single-cell, multi-region profiling of the macaque brain across the lifespan
Yang, W., Watkins, K., DeCasien, A. R., O’Neill, M. B., Bohlen, M. O., O’Day, D. R., Smith, E. A., Duran, M., 邱, 承., Meleshko, A., et al. (2026) · Cell · doi:10.1101/2025.10.31.685880 · Cited by 3
Kuehnel, H., Pasztorek, M., Kuten-Pella, O., Kramer, K., Bauer, C., Lacza, Z., & Nehrer, S. (2023) · Preprints.org · doi:10.20944/preprints202312.0304.v1 · Cited by 1
Microvesicle-Mediated Tissue Regeneration Mitigates the Effects of Cellular Ageing
Panagiotou, N., McGuinness, D., Jaminon, A. M. G., Mees, B., Selman, C., Schurgers, L. J., & Shiels, P. G. (2023) · Cells · doi:10.3390/cells12131707 · Cited by 2
The vascular phenotype in hypertension
Touyz, R. M., Rios, F. J. O., Montezano, A. C. I., Neves, K. B., Eluwole, O. A., Maseko, M. J., Alves-Lopes, R., & Camargo, L. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822546-2.00022-8 · Cited by 3
Gallicchio, L. M., Brick, R. S., Tesauro, G., Page, L. L., Green, P. A., & Guida, J. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19414 · Cited by 4
Oxidative Stress Induced Senescence Gives Rise to Transcriptionally Distinct Physiological StatesPreprint
Burnaevskiy, N., Oshima, J., & Mendenhall, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.18.492555 · Cited by 1
Multivalent cannabinoid epigenotoxicities and multigenerational aging
Reece, A. S., & Hulse, G. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13492-0.00001-3 · Cited by 2
Clearance of Senescent Cells by BCL XL ‐ PROTAC : A Novel Approach to Treat COPD ?
Devulder, J. V., Fenwick, P. S., Kołosionek, E., Al‐Sahaf, M., Viola, P., Lemaire, R., Razdan, N., Kudo, H., Sinadinos, A., Odqvist, L., et al. (2026) · Aging Cell · doi:10.1111/acel.70487 · Cited by 1
“The selective elimination of senescent cells in a BubR1 progeroid mouse model delayed the onset of age-related phenotypes and extended the healthspan of these mice (Baker et al. 2016).”
Qiao, Z., Zhang, H., Zou, H., Meng, Y., Duo, L., Wang, X., Xie, Q., Fu, X., Qi, W., & You, C. (2025) · Food Frontiers · doi:10.1002/fft2.70137 · Cited by 2
Liver diseases fibrosis and cirrhosis
Bird, T. G., & Kiourtis, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00004-3 · Cited by 1
Freizus, N., Majewska, J., Ovadya, Y., Petrovich‐Kopitman, E., Porat, Z., Mayo, A., Salame, T., Dassa, B., Stelzer, G., Alon, U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.30.691415 · Cited by 1
“…expression of V1B2 on the cell surface of senescent epithelial cells is increased in vivo in a lung fibrosis model, though its expression is heterogonous among SnCs. (SnCs) not only contribute to a variety of age-related diseases but also drive tissue ageing through their accumulation 29,31–34 .”
Toward an ethical framework for geroscience?
Faragher, R. (2023) · Advances in biogerontology · doi:10.1016/bs.abger.2023.06.001 · Cited by 1
Langreth, D. C. (1964) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis
Kuehnemann, C., Jezak, S. T., Mogck, B. A., Kura, N., Tariq, R., Che, Y., Vaittinen, M., Siokas, I., Deshpande, S., Guthrie, C., et al. (2026) · Cell · doi:10.1101/2024.10.03.616257 · Cited by 1
SGLT2 regulates immune-mediated senolysis
Guo, G., & Amor, C. (2024) · Nature Aging · doi:10.1038/s43587-024-00651-x · Cited by 2
Immunesenescence and Compromised Removal of Senescent Cells: Implications for Health in Old Age
Hazeldine, J., & Lord, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_3 · Cited by 1
Lin, N., Zhang, Z., Sha, X., Yao, J., Sun, X.-Z., Sun, R., 杨佳佳, Yu, Q., Wu, Z., Guan, J., et al. (2026) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2026.05.005 · Cited by 1
Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice
Lin, Y., Wang, B., Huang, M., Wolters, J. C., & Demaria, M. (2025) · Advanced Science · doi:10.1002/advs.202509444 · Cited by 2
Conte, T. C., Duran-Bishop, G., Orfi, Z., Mokhtari, I., Deprez, A., Roussel, M., Côté, I., Pellerito, O., Maggiorani, D., Benabdallah, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.22.497227 · Cited by 1
Senescence in non-cancerous cells within the tumor: What is the real deal?
Perramon‐Güell, A., & Anerillas, C. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189654 · Cited by 1
DNA Damage, Transposable Element Expression and Their Associated Factors in Aging
Mitiku, T., Abebe, B., Birhane, N., & Getie, B. (2024) · Biochemistry and Molecular Biology · doi:10.11648/j.bmb.20240904.11 · Cited by 2
Cabral, J. E., Lin, S., Zhou, H., Wu, A., Lackner, A., Pham, M. A., Chi, F., & McNulty, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642110 · Cited by 1
“For example, in macrophages there is a high IL-1 b dominant SASP, and ox-mtDNA-STING induced SASP is low(35).”
A novel platform for precise senolysis
Conti, A., & Micco, R. D. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112056 · Cited by 2
Meng, B., Li, X., Yang, B., Qu, Y., He, Y., Fu, C., An, Z., Wu, A., Hei, Y., Zhang, R., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5391649 · Cited by 1
Dayel, A. F. B., Alonazi, A. S., Alhajjari, A. Z., Alwakail, D. A., Alamin, M. A., Alrajeh, H. M., Alameen, A. A., El-Nagar, D. M., & Al-Rasheed, N. M. (2026) · Pharmaceuticals · doi:10.3390/ph19101548
Senolytic effects of first and second generation BCL-xL/BCL-2 dual degraders
Berezhnaya, E. S., & Savustyanenko, A. V. (2026) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2026-14-2-136-146 · Cited by 1
Seton-Rogers, S. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.20
Why do older people heal more slowly?
Steinhauser, M. L. (2020) · doi:10.64628/aai.mr63pthws
Elfita, L., Wientarsih, I., Sajuthi, D., Bachtiar, I., & Darusman, H. S. (2021) · Jurnal Sains Farmasi & Klinis · doi:10.25077/jsfk.8.1.19-26.2021
Introduction to Cellular Senescence and Aging
Banerjee, P., Al‐Anazi, K. M., Farah, M. A., & Qamar, I. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_1 · Cited by 1
Obesity, old age, and immunosenescence
Tizard, I. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44863-8.00022-3
Séguin, P., Arnouat, M., & Launey, Y. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.09.002 · Cited by 1
Grundlagen der Biogerontologie
Richter, K. (2017) · Springer eBooks · doi:10.1007/978-3-658-19973-9_6
Wang, X., Huang, Y., Zhu, T., & Qiu, H. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101175
Elimination of Senescent Cells by Polyphenols and Flavonoids
Harald, A. K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_1
Dey, A., Nethaji, K., Banerjee, A., Duss, R., Pathak, S., & Duttaroy, A. K. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107283 · Cited by 2
Grycan, M., Zyśk, R., Grycan, G., Jakiel, G., Dudek, A., & Gromadzka, G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177521
Zayan, T. A., & Khafagy, H. A. (2026) · World Advances in Renal Medicine · doi:10.25259/warm_15_2026
How to Treat or Prevent, or Slow Down, Cellular Ageing and Senescence?
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_7
Understanding extracellular vesicles in antiaging
Ahmad, P., Estrin, N. E., Sculean, A., & Miron, R. J. (2026) · Periodontology 2000 · doi:10.1111/prd.70070
Elimination of Senescent Cells by Polyphenols and Flavonoids
Harald, A. K. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_1-1
Proteomic analysis of human keratinocytes under UVA-induced stress
Valerio, H. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-28042022-144138
Zhang, X. D., Atalla, N. A., Rodriguez, E., Teng, C., Bai, X., & Teng, J. M. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-38877-x
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_10
Cellular senescence in migraine – a hypothesis-driven narrative review
Fila, M., Krekora, J., Pawłowska, E., Dróżdż, J., Ogrodnik, M. B., & Błasiak, J. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-026-02347-6 · Cited by 2
“As people age, the body’s ability to clear senescent cells diminishes, leading to their buildup and increased secretion of pro-inflammatory SASP factors, which ultimately contribute to the development of age-related diseases [20].”
Resolving chromatin interaction and transcriptional networks in mammalian nuclei
Zhu, Y. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10618
Changes of major genes related to cellular senescence in gliomaPreprint
Pećina‐Šlaus, N., Težak, J., Babić, K., Štajduhar, A., & Hrašćan, R. (2026) · Research Square · doi:10.21203/rs.3.rs-9084247/v1
Waaijer, M. E. C., Tuttle, C. S. L., Westendorp, R. G. J., & Maier, A. B. (2018) · VU Research Portal
Baker, A. G., Ou, H., Hartono, M., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., Sanghera, C., González‐Gualda, E., Macías, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.12.548691
Hematopoietic Rejuvenation via Natural Senolytic NSPCC1 Delays Inflammatory Aging
Wang, W. W., Yang, S., Zhang, R., Wang, Y., Zhang, Z., Xiao, F., Wu, S., Ju, Z., He, R., & Ge, Y. (2026) · Biology · doi:10.3390/biology15120922
“They secreted various cytokines/chemokines to recruit immune cells for clearance, but the senescent microenvironment induced immunosenescence, reducing clearance efficiency [29].”
Loss of sirtuin 3 disrupts cellular senescence signaling pathways
Kura, N., Mogck, B. A., Jezak, S. T., Velarde, M. C., & Wiley, C. D. (2026) · GeroScience · doi:10.1007/s11357-026-02284-x · Cited by 2
“Clearance of senescent cells in mice has been linked to both health span and lifespan extension [3, 8].”
Tan, J., Xiong, W., Feng, Y., Li, X., Jiang, H., & Zhang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1845117 · Cited by 1
“We fi rst assessed the expression of classic senescence-associated proteins, including p53/p21 and p16 in the tumor suppressor pathways, and Gpnmb in the skin (23 – 26).”
Xue-ting, Y., ZHANG, J.-Y., ZHENG, T.-J., Wang, X., Hai-Lin, W. A. N. G., Zeng-Di, W. E. N., Jia-Yu, S. U. N., Yu, G. U. O., Cao, D., Ying, Y. A. N. G., et al. (2026) · Shengming kexue · doi:10.3724/cbls.2026097
Characterization and therapeutic targeting of Parkinson’s-related LRRK2
Soliman, A. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.206456287
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.